MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TMDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TransMedics Group (TMDX) Earnings Date & Reports

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states... Show more

A.I. Advisor
published Earnings

TMDX is expected to report earnings to fall 30.95% to 30 cents per share on November 04

TransMedics Group TMDX Stock Earnings Reports
Q3'26
Est.
$0.30
Q2'26
Missed
by $0.09
Q1'26
Missed
by $0.32
Q4'25
Beat
by $2.23
Q3'25
Beat
by $0.30
The last earnings report on August 04 showed earnings per share of 43 cents, missing the estimate of 52 cents. With 311.54K shares outstanding, the current market capitalization sits at 3.29B.
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)
Annualized Return+20%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
TMDX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for TMDX
A.I. Advisor
published General Information

General Information

a developer of a proprietary system for preserving human organs for transplant

Industry MedicalNursingServices

Profile
Details
Industry
Medical Specialties
Address
200 Minuteman Road
Phone
+1 978 552-0900
Employees
584
Web
https://www.transmedics.com